Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 1525 of 543136 entries
View as:

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Phase: N/A Priority: Normal
NCT ID: NCT05153499 Org: User:
Start: 11/15/21 End: 02/24/23 Due: 02/24/24

Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique

Phase: N/A Priority: Normal
NCT ID: NCT02982096 Org: User:
Start: 08/23/16 End: 12/01/22 Due: 12/01/23

Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses

Phase: N/A Priority: Normal
NCT ID: NCT02651961 Org: User:
Start: 05/03/18 End: 10/02/22 Due: 10/02/23

Assessments of Dynamic Variables of Fluid Responsiveness to Predict Desufflation-induced Hypotension in Urologic Patients Undergoing Laparoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03967119 Org: User:
Start: 04/25/19 End: 04/30/22 Due: 04/30/23

Redes II National Patient Navigator Intervention Study

Phase: N/A Priority: Normal
NCT ID: NCT02269033 Org: User:
Start: 09/30/08 End: 09/30/10 Due: 09/30/11

Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS

Phase: N/A Priority: Normal
NCT ID: NCT06143488 Org: User:
Start: 01/04/24 End: 09/30/25 Due: 09/30/26

The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient

Phase: N/A Priority: Normal
NCT ID: NCT02261545 Org: User:
Start: 09/30/14 End: 02/29/16 Due: 02/28/17

Symptom Management Essentials at Home

Phase: N/A Priority: Normal
NCT ID: NCT06434545 Org: User:
Start: 11/01/21 End: 07/01/26 Due: 07/01/27

25gr. Glucomedics vs 25gr. Zusto

Phase: N/A Priority: Normal
NCT ID: NCT02607345 Org: User:
Start: 02/28/15 End: 04/30/15 Due: 04/30/16

Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00666835 Org: User:
Start: 04/30/04 End: 01/31/06 Due: 01/31/07

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02499835 Org: User:
Start: 07/01/15 End: 07/27/23 Due: 07/27/24

A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01906658 Org: User:
Start: 07/31/13 End: 12/31/14 Due: 12/31/15

Nordic Bifurcation Stent Technique Study (BIF II)

Phase: N/A Priority: Normal
NCT ID: NCT00292305 Org: User:
Start: 09/30/05 End: 12/31/12 Due: 12/31/13

Cardiovascular Assessment of Pediatric Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05939089 Org: User:
Start: 01/01/23 End: 06/22/23 Due: 06/22/24

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01399684 Org: User:
Start: 11/30/11 End: 02/28/14 Due: 02/28/15

Glulisine + Lantus in Type I Patients

Phase: N/A Priority: Normal
NCT ID: NCT00546702 Org: User:
Start: 09/30/04 End: 02/28/05 Due: 02/28/06

Measuring the Spectrum of Tissues During Endoscopy

Phase: N/A Priority: Normal
NCT ID: NCT00996619 Org: User:
Start: 10/31/09 End: 05/31/10 Due: 05/31/11

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

Phase: N/A Priority: Normal
NCT ID: NCT00311532 Org: User:
Start: 03/31/06 End: 05/31/07 Due: 05/31/08

Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194777 Org: User:
Start: 06/30/01 End: - Due: -

Effectiveness of SisterTalk Hartford for Weight Loss Among African-American Women

Phase: N/A Priority: Normal
NCT ID: NCT01282749 Org: User:
Start: 10/31/02 End: 08/31/06 Due: 08/31/07

Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06197841 Org: User:
Start: 12/01/23 End: 12/31/24 Due: 12/31/25

A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00271466 Org: User:
Start: 02/29/00 End: 04/30/02 Due: 04/30/03

OSA in Pregnant Women With Chronic HTN

Phase: N/A Priority: Normal
NCT ID: NCT03230110 Org: User:
Start: 06/16/17 End: 04/30/19 Due: 04/30/20

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

Phase: N/A Priority: Normal
NCT ID: NCT00571558 Org: User:
Start: 03/31/08 End: 11/30/10 Due: 11/30/11

Proof-of-concept Study for Bioimpedance Based Monitoring of Venous Ulcers During Galvanic Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT02101645 Org: User:
Start: 03/31/14 End: 12/31/14 Due: 12/31/15